NFKB1 and aneurysmal bone cyst: The two major subgroups of DLBCL according to the COO, GCB, and ABC, identified by gene-expression profiling, differ in the activation of distinctive signaling pathways, with the ABC subgroup relying on chronic B-cell receptor signaling and the constitutive activation of nuclear factor κB (NF-κB) [26].